<DOC>
	<DOCNO>NCT00297349</DOCNO>
	<brief_summary>The purpose observational study evaluate safety topiramate use combination medication seizures adult child .</brief_summary>
	<brief_title>A Study Safety Topiramate Given Combination With Other Medications Adults Children With Seizures</brief_title>
	<detailed_description>Topiramate medication approve treatment seizure . In accordance International guideline , study conduct drug market continue evaluate expand knowledge regard safety . This open-label , multi-center observational safety study collect safety information oral topiramate give addition medication 3 type seizure adult child age 2 year older.The 3 seizure type focal epilepsy , LENNOX-GASTAUT syndrome epileptic seizure generalize tonic-clonic seizure . Patients whose previous treatment seizure ( one antiepileptic drug ) judge physician non-satisfactory receive 6 month treatment topiramate addition antiepileptic medication prescribe physician . Topiramate give low dos initially gradually increased necessary control seizure activity accordance Summary Product Characteristics ( SmPC ) . Patients ask keep diary adverse event seizure activity . Safety evaluation ( incidence adverse event , physical examination , vital sign laboratory test ) perform throughout study per investigator usual standard care . At end study , treat physician may continue treatment topiramate medication appropriate . The study hypothesis topiramate give combination antiepileptic medication effective achieve maintain control seizure activity well-tolerated . 225 adult patient child age 2 year old enrol study . Study participant demonstrate focal epilepsy epileptic seizure LENNOX-GASTAUT syndrome generalize tonoclonic seizure , undergone treatment one antiepileptic drug whose treatment judge investigator non-satisfactory . Observational study - No investigational drug administer .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lennox Gastaut Syndrome</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Nonpremenopausal female patient use medically acceptable contraceptive method discuss doctor History type seizure period prior inclusion study sufficient medical record document . Prior treatment inclusion study one antiepileptic drug treatment judge nonsatisfactory investigator Patients suffer epilepsy , whose seizure due cause include disease , exposure harmful substance , active infection tumor Patients history generalize status epilepticus ( prolonged seizure ) within last three month Patients progressive brain tumor progressive degenerative disorder Patients history ( within previous six month ) mental emotional disorder require shock treatment major sedation , monoamine oxidase ( MAO ) inhibitor medication affect central nervous system Patients medical social condition may affect ability take part study safety study Patients take drug fill diary , either alone help . If help need , permanently available throughout study</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Seizures</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Tonic-clonic</keyword>
	<keyword>Lennox-Gastaut Syndrome</keyword>
	<keyword>Focal Epilepsy</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Epilepsy Children</keyword>
</DOC>